BioGlue Surgical Adhesive
Cryolife, Inc. · Decision date Jul 15, 2026
What did the FDA approve?
FDA records P010003/S043 as a supplement to PMA P010003, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 15, 2026.
FDA approval order statement
approval for transferring the 2 mL BioGlue Surgical Adhesive fill from the currently approved 5 mL syringe body to the larger 10 mL syringe body and requested to extend the shelf life from 21 to 24 months for the 2 mL configuration.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 15, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P010003/S043
- Regulatory pathway
- PMA supplement
- Applicant
- Cryolife, Inc.
- Product code
- MUQ
- Decision code
- APPR
- Decision date
- Jul 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Glue, surgical, arteries.
- Applicant
- Cryolife, Inc.
- Product code
- MUQ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P010003/S043 received
Application receipt date recorded by FDA.
P010003/S043 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P010003. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cryolife, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1655 Roberts Blvd. NW, Kennesaw, GA, 30144
Sources and methodology
- Original FDA record: P010003/S043
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records